Cantor Fitzgerald, L. P. »

Atrium Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 236k 13.37

More positions owned by Cantor Fitzgerald, L. P.

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Advanced Micro Devices Put Option (AMD)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Iren Ordinary Shares (IREN)
UnitedHealth Put Option (UNH)
Circle Internet Group Com Cl A Put Option (CRCL)
Broadcom (AVGO)
Bitmine Immersion Tecnologie Com New (BMNR)
Robinhood Mkts Com Cl A (HOOD)
Intel Corporation (INTC)
Servicenow Put Option (NOW)
Oracle Corporation (ORCL)
Amazon (AMZN)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics